Skip to main content
Log in

Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tóth M, Bajnógel J, Egyed A, Drabant S, Tömlö J, Klebovich I (2005) Effect of tofisopam on human recombinant 3A4 supersome. Acta Pharm Hung 75:195–198

    PubMed  Google Scholar 

  2. van Gelder T (2002) Drug interaction with tacrolimus. Drug Safety 25:707–712

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sándor Drabant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drabant, S., Tóth, M., Bereczki, A. et al. Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam. Eur J Clin Pharmacol 62, 587–588 (2006). https://doi.org/10.1007/s00228-006-0160-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-006-0160-9

Keywords

Navigation